Torray Fund recent buys & sells (2026 Q2)
Robert Torray
Torray Fund Portfolio Changes
Purchase & sale details
- Portfolio value:
- $355.04M (+$14M)
- Previous value:
- $341.34M
- # of changes:
- 17
- New positions:
- 1
- Reported for:
- 31 May 2026 (Q2)
- Latest filing date:
- 09 Oct 2026
Torray Fund has disclosed a total of 17 changes to the portfolio in the latest (2026 Q2) SEC report(s): increased the number of shares of 8, bought 1 totally new, decreased the number of shares of 7 and completely sold out 1 position(s).
What stocks is Torray Fund buying now?
In the recent quarter Torray Fund has bought 9 securities out of which top 5 purchases (by % change to portfolio) are (KKR 6.25 03.01.28 D) KKR & CO INC (added shares +76.92%), (ABBV) AbbVie Inc (added shares +7.70%), (MSFT) Microsoft Corp (added shares +40.00%), (NEE) Nextera Energy Inc (added shares +16.67%) and (AMGN) Amgen Inc (added shares +12.50%).
What does Torray Fund invest in?
Torray Fund's top 5 holdings (by % of portfolio) are (KKR 6.25 03.01.28 D) KKR & CO INC (6.76%), (TXN) Texas Instruments Incorporated (6.31%), (AVGO) Broadcom Inc (5.98%), (HPE 7.625 09.01.27) HP ENTERPRISE CO (5.45%) and (RPRX) Royalty PharmaPlc (4.71%).
In the latest report(s) the following changes have been made to the top investments: (KKR 6.25 03.01.28 D) KKR & CO INC (added shares +76.92%), (TXN) Texas Instruments Incorporated (reduced shares -26.73%), (HPE 7.625 09.01.27) HP ENTERPRISE CO (reduced shares -36.36%) and (RPRX) Royalty PharmaPlc (reduced shares -14.29%).
17 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Comcast Corp
|
new
|
+575,000
|
575,000
|
+4.03%
|
$24.87
|
-16.26%($20.82)
|
4.03%
|
2026 Q2
|
~0.25 years
|
|
|
|
FIDELITY INV MMKT GOVT-I
|
+86.14%
|
+1,925,073.12
|
4,159,843.05
|
+0.54%
|
$1.00
|
0.00%($1.00)
|
1.17%
|
2020 Q1
|
~6.50 years
|
|
|
|
KKR & CO INC
|
+76.92%
|
+250,000
|
575,000
|
+2.94%
|
$41.76
|
|
6.76%
|
2025 Q4
|
~0.75 years
|
|
|
|
Microsoft Corp
|
+40.00%
|
+10,000
|
35,000
|
+1.27%
|
$450.24
|
+21.42%($546.67)
|
4.44%
|
2026 Q1
|
~0.50 years
|
|
|
|
Nextera Energy Inc
|
+16.67%
|
+25,000
|
175,000
|
+0.61%
|
$87.01
|
-9.94%($78.36)
|
4.29%
|
2025 Q3
|
~1.00 year
|
|
|
|
Amgen Inc
|
+12.50%
|
+5,000
|
45,000
|
+0.47%
|
$336.79
|
+22.47%($412.46)
|
4.27%
|
2024 Q4
|
~1.75 years
|
|
|
|
AbbVie Inc
|
+7.70%
|
+5,360
|
75,000
|
+0.33%
|
$217.72
|
+26.28%($274.94)
|
4.60%
|
2025 Q2
|
~1.25 years
|
|
|
|
Marsh & McLennan Companies, Inc
|
+7.14%
|
+5,000
|
75,000
|
+0.23%
|
$159.97
|
+11.10%($177.73)
|
3.38%
|
2020 Q1
|
~6.50 years
|
|
|
|
Blackstone Group Inc
|
+4.17%
|
+5,000
|
125,000
|
+0.16%
|
$116.97
|
-5.69%($110.32)
|
4.12%
|
2025 Q2
|
~1.25 years
|
|
|
|
Pfizer Inc
|
-4.17%
|
-25,000
|
575,000
|
-0.19%
|
$26.18
|
+8.10%($28.30)
|
4.24%
|
2025 Q2
|
~1.25 years
|
|
Insights | News
Insight
—
Re-entry · 2026 Q2
Insight
Insight
—
Position exited · 2026 Q2
Insight
—
New top holding · 2026 Q2
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".